406 related articles for article (PubMed ID: 26369382)
41. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
42. Maternal serum human chorionic gonadotropin and pregnancy-associated plasma protein-A in pregnancies with fetal homozygous α-thalassemia-1 disease.
Tongprasert F; Wanapirak C; Tongsong T
Prenat Diagn; 2012 Jul; 32(7):700-2. PubMed ID: 22508575
[TBL] [Abstract][Full Text] [Related]
43. Elevated alpha-fetoprotein levels in the 45,x (Turner syndrome) fetus with cystic hygroma. Case reports.
Rosendorff J; Mayo JR; Reichman P; Pinto MR; Bernstein R
S Afr Med J; 1982 Oct; 62(17):621-4. PubMed ID: 6181571
[TBL] [Abstract][Full Text] [Related]
44. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
45. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
46. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
[TBL] [Abstract][Full Text] [Related]
47. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE
Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
[TBL] [Abstract][Full Text] [Related]
48. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
49. Combined screening for open spina bifida at 11-13 weeks using fetal biparietal diameter and maternal serum markers.
Bernard JP; Cuckle HS; Bernard MA; Brochet C; Salomon LJ; Ville Y
Am J Obstet Gynecol; 2013 Sep; 209(3):223.e1-5. PubMed ID: 23673229
[TBL] [Abstract][Full Text] [Related]
50. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
51. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
52. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
[TBL] [Abstract][Full Text] [Related]
53. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
[TBL] [Abstract][Full Text] [Related]
54. Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies.
Steier JA; Myking OL; Bergsjø PB
Acta Obstet Gynecol Scand; 1999 May; 78(5):367-71. PubMed ID: 10326878
[TBL] [Abstract][Full Text] [Related]
55. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
56. [Relationship of mid-trimester serum screening markers and adverse pregnancy outcomes].
Zhang Y; Zhai Y; Liu H; Li Y; Lu J; Zhang Z
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):379-81. PubMed ID: 24746088
[TBL] [Abstract][Full Text] [Related]
57. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
58. Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong.
Law L; Lau T; Fung T; Rogers MS; Hjelm M
Chin Med J (Engl); 1999 Aug; 112(8):754-7. PubMed ID: 11601289
[TBL] [Abstract][Full Text] [Related]
59. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies.
Maymon R; Shulman A
Hum Reprod; 2001 Apr; 16(4):691-5. PubMed ID: 11278220
[TBL] [Abstract][Full Text] [Related]
60. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.
Lepage N; Chitayat D; Kingdom J; Huang T
Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
